Status:
UNKNOWN
Neural Predictors and Neural Changes Associated With Cognitive Behavior Therapy for Obssesive Compulsive Disorder
Lead Sponsor:
Institut d'Investigació Biomèdica de Bellvitge
Collaborating Sponsors:
Institut d'Investigacions Biomèdiques August Pi i Sunyer
FIDMAG Germanes Hospitalàries
Conditions:
Obsessive-Compulsive Disorder (OCD)
Eligibility:
All Genders
8-60 years
Phase:
NA
Brief Summary
The goals of the project are 1) to understand what are the neural mechanisms involved in the psychological treatment of obsessive-compulsive disorder (OCD) in children/adolescents and adults, 2) to as...
Detailed Description
Obsessive-compulsive disorder (OCD) is a frequent and disabling disorder. Cognitive-behavior therapy (CBT) is the best treatment option available for OCD, although it achieves optimum results in less ...
Eligibility Criteria
Inclusion
- (same for Study 1 and Study 2):
- Principal diagnosis of OCD;
- Y-BOCS or CYBOCS ≥ 16).
- No current psychotropic medication (except benzodiacepines for sleep). 4 ) Age between 8 and 17 years (Study 1) and between 18 and 60 years (Study 2).
Exclusion
- (same for Study 1 and Study 2
- Current major depression or current/past psychosis, bipolar disorder or substance abuse.
- Developmental disorders (including autistic spectrum disorders).
- To be pregnant or during breastfeeding
- Current CBT; nt.
- Any severe medical disorder ;
- Any contraindication for neuroimaging
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04042038
Start Date
May 1 2019
End Date
September 1 2023
Last Update
March 1 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
IDIBELL
L'Hospitalet de Llobregat, Barcelona, Spain, 08907
2
FIDMAG Germanes Hospitalàries
Sant Boi de Llobregat, Barcelona, Spain, 08035
3
IDIBAPS
Barcelona, Spain, 08036